| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.29 |
2e-15 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.37 |
2e-10 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
4e-09 |
| mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
2e-08 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.31 |
7e-08 |
| mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
9e-08 |
| mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
1e-07 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-07 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-07 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-06 |